🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Randomized phase III trial to compare the effectiveness of different chemot...
Status
Completed
Location
Children's Oncology Group
Start Date
1996-08
Trial ID
NCT00002798
The purpose of this study is to provide data on the activity of a standard ...
Status
Terminated
Location
Multiple Locations
Start Date
2011-03-03
Trial ID
NCT01177540
Treatments Being Tested
This is a dose escalation study to evaluate Omacetaxine when given in combi...
Status
Terminated
Location
University of Illinois at Chicago
Start Date
2015-06-05
Trial ID
NCT02440568
Chronic myofascial neck pain (CMNP) is a painful non-articular musculoskele...
Status
Recruiting
Location
Cairo University
Start Date
2026-06-01
Trial ID
NCT07692126
The purpose of this study is: 1. To compare priming with Granulocyte-Macro...
Status
Completed
Location
Multiple Locations
Start Date
1999-03
Trial ID
NCT00880243
Treatments Being Tested
The primary objective of this study is to evaluate the efficacy of tisleliz...
Status
Terminated
Location
Beijing Cancer Hospital
Start Date
2020-12-14
Trial ID
NCT04486391
Treatments Being Tested
The protocol objective is providing adequate treatment and based on broad c...
Status
Unknown
Location
Hospital Germans Trias i Pujol and all Hospital Pethema
Start Date
2007-06-30
Trial ID
NCT01366898
Treatments Being Tested
Based on the further need to improve progression-free survival (PFS) and ov...
Status
Completed
Location
Washington University School of Medicine
Start Date
2017-08-01
Trial ID
NCT03072771
The purpose of this trial is to test the safety and tolerance of the combin...
Status
Terminated
Location
Neurologische Universitaetsklinik Bonn
Start Date
2012-03
Trial ID
NCT01563614
RATIONALE: Imatinib mesylate may stop the growth of cancer cells by blockin...
Status
Completed
Location
Cleveland Clinic Taussig Cancer Center
Start Date
2003-07
Trial ID
NCT00268229
Treatments Being Tested